Scott Mosley, PharmD, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy. His research is focused in pharmacogenomics implementation, which incorporates genetic information with other clinical factors to optimize drug selection.
He received a BS in biochemical/biophysical science from the University of Houston in 2006, then worked as an analytical chemist in a core pharmacology lab for MD Anderson Cancer Center in Houston. He received his PharmD degree from the University of Texas in 2013, and then took a position as a pharmacist with MD Anderson Cancer Center.
He completed a postdoctoral research fellowship at the University of Florida College of Pharmacy in the Center for Pharmacogenomics under the mentorship of Larisa Cavallari, PharmD. During that time, Mosley carried out a research protocol to assess the value of utilizing CYP2D6 genotype to guide opioid selection for patients with cancer pain.